Caffo O - Search Results

1

Oral selective estrogen receptor degraders (SERDs): The new emperors in breast cancer clinical practice?

Ferro A, Generali D, Caffo O, Caldara A, De Lisi D, Dipasquale M, Lorenzi M, Monteverdi S, Fedele P, Ciribilli Y. Ferro A, et al. Among authors: caffo o. Semin Oncol. 2023 Jun-Oct;50(3-5):90-101. doi: 10.1053/j.seminoncol.2023.08.002. Epub 2023 Aug 26. Semin Oncol. 2023. PMID: 37673696 Review.

2

Pain and quality of life after surgery for breast cancer.

Caffo O, Amichetti M, Ferro A, Lucenti A, Valduga F, Galligioni E. Caffo O, et al. Breast Cancer Res Treat. 2003 Jul;80(1):39-48. doi: 10.1023/A:1024435101619. Breast Cancer Res Treat. 2003. PMID: 12889597

3

Development and daily use of an electronic oncological patient record for the total management of cancer patients: 7 years' experience.

Galligioni E, Berloffa F, Caffo O, Tonazzolli G, Ambrosini G, Valduga F, Eccher C, Ferro A, Forti S. Galligioni E, et al. Among authors: caffo o. Ann Oncol. 2009 Feb;20(2):349-52. doi: 10.1093/annonc/mdn567. Epub 2008 Aug 20. Ann Oncol. 2009. PMID: 18718889 Free article.

4

Multicenter phase 2 study of combined gemcitabine and epirubicin as second-line treatment for patients with advanced ovarian cancer.

Murgia V, Sorio R, Griso C, Caffo O, Arcuri C, Ferro A, Caldara A, Scalone S, Arisi E, Galligioni E. Murgia V, et al. Among authors: caffo o. Int J Gynecol Cancer. 2010 Aug;20(6):953-7. doi: 10.1111/IGC.0b013e3181e4a6c1. Int J Gynecol Cancer. 2010. PMID: 20683401 Clinical Trial.

5

Multiple rechallenges for castration-resistant prostate cancer patients responding to first-line docetaxel: assessment of clinical outcomes and predictive factors.

Caffo O, Pappagallo G, Brugnara S, Caldara A, di Pasquale MC, Ferro A, Frisinghelli M, Murgia V, Russo LM, Soini B, Valduga F, Veccia A, Galligioni E. Caffo O, et al. Urology. 2012 Mar;79(3):644-9. doi: 10.1016/j.urology.2011.11.043. Urology. 2012. PMID: 22386418

6

An evaluation of the pharmacokinetics and clinical use of vinorelbine for NSCLC treatment.

Caffo O, Dipasquale M, Murgia V, Veccia A, Galligioni E. Caffo O, et al. Expert Opin Drug Metab Toxicol. 2013 Aug;9(8):1037-51. doi: 10.1517/17425255.2013.804065. Epub 2013 May 27. Expert Opin Drug Metab Toxicol. 2013. PMID: 23705788 Review.

7

Splice Variants of Androgen Receptor and Prostate Cancer.

Caffo O, Maines F, Veccia A, Kinspergher S, Galligioni E. Caffo O, et al. Oncol Rev. 2016 May 30;10(1):297. doi: 10.4081/oncol.2016.297. eCollection 2016 Apr 15. Oncol Rev. 2016. PMID: 27471583 Free PMC article. Review.

8

Weekly paclitaxel after first-line failure in patients with advanced non-small-cell lung cancer: everyday clinical practice in a single centre.

Dipasquale M, Murgia V, Veccia A, Brugnara S, Caldara A, Ferro A, Frisinghelli M, Maines F, Trentin C, Valduga F, Caffo O. Dipasquale M, et al. Among authors: caffo o. Anticancer Drugs. 2017 Jul;28(6):654-659. doi: 10.1097/CAD.0000000000000482. Anticancer Drugs. 2017. PMID: 28252532

9

Modified 3-week schedule of gemcitabine plus cisplatin for non-small cell lung cancer treatment.

Veccia A, Murgia V, Dipasquale M, Caffo O. Veccia A, et al. Among authors: caffo o. J BUON. 2017 Nov-Dec;22(6):1395-1403. J BUON. 2017. PMID: 29332329 Free article.

10

Nasopharyngeal swab or clinical-radiological evidence: the dark side of the moon for cancer patients in the COVID-19 era.

Veccia A, Kinspergher S, Dipasquale M, Caffo O. Veccia A, et al. Among authors: caffo o. Future Oncol. 2020 Jul;16(19):1321-1322. doi: 10.2217/fon-2020-0372. Epub 2020 May 26. Future Oncol. 2020. PMID: 32452225 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters